| [1] |
Fradet Y, Klotzl, Trachtenberg J, et al. The burden of prostate cancer in Canada[J]. Can Urol Assoc J, 2009, 3(3 Suppl 2): 92-100.
|
| [2] |
He HQ, Fan SF, Yang AC, et al. ADC values and Gleason scores of prostate cancer clinical stage and the correlation of PSA study [J] Yi Xue Ying Xiang Xue Za Zhi, 2009, 19(5): 587-591. [何海 清, 樊树峰, 杨爱春, 等. 前列腺癌ADC值与Gleason评分、临 床分期及PSA的相关性研究[J]. 医学影像学杂志, 2009, 19(5): 58 7-91.]
|
| [3] |
Freedland SJ, Moul JW. Prostate specific antigen recurrence after definitive therapy[J]. J Urol, 2007, 177(6): 1985-91.
|
| [4] |
Lin NZ, Xia M. Biochemical recurrence after the eradicative resection of prostate cancer risk factors and prediction research progress[J]. Zhonghua Yi Xue Za Zhi, 2009, 89(24): 1721-3. [林 宁珠, 夏溟. 前列腺癌根治术后生化复发危险因素及预测研究 进展[J] 中华医学杂志, 2009, 89(24): 1721-3.]
|
| [5] |
Pollack A, Hanlon AL, Horwitz EM, et al. Prostate cancer radiotherapy dose response: an update of the fox chase experience[J]. J Urol, 2004, 171(3): 1132-6.
|
| [6] |
Zanatta DA, Andrade RJ, Pacagnan EF, et al. Early stage prostate cancer: biochemical recurrence after treatment[J]. Int Braz J Urol, 20 14, 40(2): 137-45.
|
| [7] |
Lee JT, Lee S, Yun CJ, et al. Prediction of perineural invasion and its prognostic value in patients with prostate cancer[J]. Korean J Urol, 2010, 51(11): 745-51.
|
| [8] |
Siddiqui SA, Sengupta S, Slezak JM, et al. Impact of patient age at treament on outcome following radical retropubic prostatectomy for prostate cancer[J]. J Urol, 2006, 175(3 Pt 1): 952-7.
|
| [9] |
Magheli A, Rais-Bahrami S, Humphreys EB, et al. Impact of age on biaochemical recurrence rates following radical prostatectomy[J]. J Urol, 2007, 178(5): 1933-7.
|
| [10] |
Pfitzenmaier J, Pahemik S, Tremmel T, et al. Positive surgical margins after radical prostatectomy:do they have an impact on biochemical or clinical progression?[J]. BJU Int, 2008, 102(10): 14 13-8.
|
| [11] |
Boorjian SA, Thompson RH, Siddiqui S, et al. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era[J]. J Urol, 2007, 178(3 Pt 1): 864-70.
|
| [12] |
Fukuhara H, Kume H, Suzuki M, et al. Maximum tumor diameter: a simple independent predictor for biochemical recurrence after radical prostatectomy[J]. Prostate Cancer Prostatic Dis, 2010, 13 (3): 244-7.
|
| [13] |
Pastori J, Balssa L, Lillaz J. Existence of pattern 5 on radical prostatectomy:Poor prognostic factor associated with a lower biochemical recurrence-free survival[J]. Prog Urol, 2014, 24(7): 43 3-40.
|
| [14] |
Reese AC, Cooperberg MR, Carroll PR. Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease[J]. J Urol, 2010, 184(1): 11 4-9.
|
| [15] |
Molina Escudero R, Herranz-Amo F, Paez-Borda A. Predictive postoperative model for biochemical recurrence in patients with localized prostate cancer treated with radical prostatectomy as monotherapy[J]. Arch Esp Urol, 2014, 67(3): 259-67.
|
| [16] |
Warner JN, Nunez RN, Mmeje CO, et al. Impact of margin status at 37 months after robot assisted radical prostatectomy[J]. Can J Urol, 2011, 18(6): 6043-9.
|
| [17] |
Thompson RH, Blute ML, Slezak JM, et al. Is the GPMS scoreing alporith for patients with prostate concer valid in the contemparyera?[J]. J Urol, 2007, 178(2): 459-63.
|
| [18] |
Barry Delongchamps N, Peyromaure M, Kpatcha F, et al. pT3N0 prostate cancer treated with radical prostatectomy as sole treatment:Oncological results and predictive factors of recurrence[J]. Prog Urol, 2012, 22(2): 100-5.
|
| [19] |
Brassell SA, Kao TC, Sun L, et al. Prostate specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer[J]. Urology, 2005, 66(6): 1229-33.
|
| [20] |
Okubo H, Ohori M, Ohno Y, et al. Prediction of non-biochemical recurrence rate after radical prostatectomy in a Japanese cohort: development of a postoperative nomogram[J]. Int J Urol, 2014, 21 (5): 479-83.
|
| [21] |
Raatikainen S, Aaltomaa S, Palvimo JJ, et al. TWIST overexpression predicts biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy[J]. Scand J Urol, 2015, 49(1): 51-7.
|
| [22] |
Merglen A, Schmidlin F, Fioretta G, et al. Short-and long-term mortality with localized prostate cancer[J]. Arch Intern Med, 20 07, 167(18): 1944-50．
|
| [23] |
González-San Segundo C, Herranz-Amo F, Alvarez-González A, et al. Radical prostatectomy versus external-beam radiotherapy for localized prostate cancer：long-term effect on biochemical control-in search of the optimal treatment[J]. Ann Surg Oncol, 20 11, 18(10): 2980-7．
|
| [24] |
Arcangeli G, Strigari L, Arcangeli S, et al. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer[J]. Int J Radiat Oncol Biol Phys, 2009, 75(4): 975-82．
|
下载:
